ATE534634T1 - 2-phenyl-4-cyclopropyl-pyrimidinderivate - Google Patents

2-phenyl-4-cyclopropyl-pyrimidinderivate

Info

Publication number
ATE534634T1
ATE534634T1 AT09730987T AT09730987T ATE534634T1 AT E534634 T1 ATE534634 T1 AT E534634T1 AT 09730987 T AT09730987 T AT 09730987T AT 09730987 T AT09730987 T AT 09730987T AT E534634 T1 ATE534634 T1 AT E534634T1
Authority
AT
Austria
Prior art keywords
cyclopropyl
phenyl
pyrimidine derivatives
pyrimidine
derivatives
Prior art date
Application number
AT09730987T
Other languages
English (en)
Inventor
Eva Caroff
Emmanuel Meyer
Original Assignee
Actelion Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actelion Pharmaceuticals Ltd filed Critical Actelion Pharmaceuticals Ltd
Application granted granted Critical
Publication of ATE534634T1 publication Critical patent/ATE534634T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT09730987T 2008-04-11 2009-04-09 2-phenyl-4-cyclopropyl-pyrimidinderivate ATE534634T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IB2008051389 2008-04-11
PCT/IB2009/051498 WO2009125365A1 (en) 2008-04-11 2009-04-09 2-phenyl-4-cyclopropyl-pyrimidine derivatives

Publications (1)

Publication Number Publication Date
ATE534634T1 true ATE534634T1 (de) 2011-12-15

Family

ID=40790423

Family Applications (1)

Application Number Title Priority Date Filing Date
AT09730987T ATE534634T1 (de) 2008-04-11 2009-04-09 2-phenyl-4-cyclopropyl-pyrimidinderivate

Country Status (17)

Country Link
US (1) US8466156B2 (de)
EP (1) EP2283011B1 (de)
JP (1) JP5374578B2 (de)
KR (1) KR101610417B1 (de)
CN (1) CN101998953B (de)
AR (1) AR071653A1 (de)
AT (1) ATE534634T1 (de)
AU (1) AU2009235123A1 (de)
CA (1) CA2719569C (de)
ES (1) ES2376820T3 (de)
IL (1) IL208548A0 (de)
MA (1) MA32277B1 (de)
MX (1) MX2010010932A (de)
NZ (1) NZ589169A (de)
TW (1) TW200944516A (de)
WO (1) WO2009125365A1 (de)
ZA (1) ZA201008052B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200640877A (en) 2005-04-28 2006-12-01 Actelion Pharmaceuticals Ltd Pyrimidine derivatives
AR063258A1 (es) 2006-10-13 2009-01-14 Actelion Pharmaceuticals Ltd Derivados de 2-aminocarbonil-piridina, una composicion farmaceutica que los contiene y su uso en la preparacion de un medicamento para el tratamiento de trastornos vasculares oclusivos.
AR063518A1 (es) 2006-10-25 2009-01-28 Actelion Pharmaceuticals Ltd Derivados 2-fenil-6-aminocarbonil-pirimidina; composicion farmaceutica; y su uso para tratar y/o prevenir enfermedades vasculares perifericas viscerales, hepaticas y renales, enfermedades cardiovasculares y enfermedades cerebrovasculares asociados con la agregacion de plaquetas, incluyendo trombosis
ES2388958T3 (es) 2007-11-29 2012-10-22 Actelion Pharmaceuticals Ltd. Derivados de acido fosfonico y su uso como antagonista del receptor P2Y12
AR071652A1 (es) 2008-04-11 2010-07-07 Actelion Pharmaceuticals Ltd Derivados 2- fenil-piridina substituidos
KR101694563B1 (ko) 2009-04-08 2017-01-09 액테리온 파마슈티칼 리미티드 Adp 수용체 길항제로서 6-(3-아자-비시클로〔3.1.0〕헥스-3-일)-2-페닐-피리미딘
EP2421859B1 (de) 2009-04-22 2014-04-09 Actelion Pharmaceuticals Ltd. Thiazolderivate und ihre verwendung als p2y12 rezeptor antagonisten
WO2013033178A1 (en) 2011-08-30 2013-03-07 University Of Utah Research Foundation Methods and compositions for treating nephrogenic diabetes insipidus
HUE057772T2 (hu) 2016-09-22 2022-06-28 Idorsia Pharmaceuticals Ltd Kristályos formák
US11179390B2 (en) 2017-03-15 2021-11-23 Idorsia Pharmaceuticals Ltd Subcutaneous administration of a P2Y12 receptor antagonist

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2020437A1 (en) 1989-07-05 1991-01-06 Yoshihide Fuse Cinnamamide derivative
JPH05303586A (ja) 1992-04-07 1993-11-16 Nec Corp 高精度連立一次方程式解析装置
DE60022508T2 (de) 1999-06-14 2006-06-08 Eli Lilly And Co., Indianapolis Inhibitoren von serin proteasen
US6861424B2 (en) 2001-06-06 2005-03-01 Schering Aktiengesellschaft Platelet adenosine diphosphate receptor antagonists
OA12970A (en) 2002-12-11 2006-10-13 Schering Ag 2-aminocarbonyl-quinoline compounds as platelet adenosine diphosphate receptor antagonists.
CA2521313A1 (en) 2003-04-09 2004-10-28 Wyeth Derivatives of 2-(8,9-dioxo-2,6-diazabicyclo(5.2.o)non-1(7)-3n-2-yl)-al kyl phosphonic acid and their use as n-methyl-d-aspartate (nmda) recetor antagonists
TW200640877A (en) 2005-04-28 2006-12-01 Actelion Pharmaceuticals Ltd Pyrimidine derivatives
WO2007046075A1 (en) 2005-10-21 2007-04-26 Actelion Pharmaceuticals Ltd Piperazine derivatives as antimalarial agents
AR063258A1 (es) 2006-10-13 2009-01-14 Actelion Pharmaceuticals Ltd Derivados de 2-aminocarbonil-piridina, una composicion farmaceutica que los contiene y su uso en la preparacion de un medicamento para el tratamiento de trastornos vasculares oclusivos.
AR063518A1 (es) 2006-10-25 2009-01-28 Actelion Pharmaceuticals Ltd Derivados 2-fenil-6-aminocarbonil-pirimidina; composicion farmaceutica; y su uso para tratar y/o prevenir enfermedades vasculares perifericas viscerales, hepaticas y renales, enfermedades cardiovasculares y enfermedades cerebrovasculares asociados con la agregacion de plaquetas, incluyendo trombosis
KR20100015886A (ko) 2007-04-23 2010-02-12 사노피-아벤티스 P2y12 길항제로서의 퀴놀린-카복스아미드 유도체
ES2388958T3 (es) 2007-11-29 2012-10-22 Actelion Pharmaceuticals Ltd. Derivados de acido fosfonico y su uso como antagonista del receptor P2Y12
EP2238128B1 (de) 2007-12-26 2012-08-22 Sanofi Heterocyclische pyrazolcarboxamide als p2y12-antagonisten
WO2009080227A2 (en) 2007-12-26 2009-07-02 Sanofi-Aventis Pyrazole-carboxamide derivatives as p2y12 antagonists
AR071652A1 (es) 2008-04-11 2010-07-07 Actelion Pharmaceuticals Ltd Derivados 2- fenil-piridina substituidos
KR101694563B1 (ko) 2009-04-08 2017-01-09 액테리온 파마슈티칼 리미티드 Adp 수용체 길항제로서 6-(3-아자-비시클로〔3.1.0〕헥스-3-일)-2-페닐-피리미딘
EP2421859B1 (de) 2009-04-22 2014-04-09 Actelion Pharmaceuticals Ltd. Thiazolderivate und ihre verwendung als p2y12 rezeptor antagonisten

Also Published As

Publication number Publication date
CN101998953B (zh) 2014-12-17
TW200944516A (en) 2009-11-01
AU2009235123A1 (en) 2009-10-15
IL208548A0 (en) 2010-12-30
AR071653A1 (es) 2010-07-07
MA32277B1 (fr) 2011-05-02
US8466156B2 (en) 2013-06-18
US20110028484A1 (en) 2011-02-03
EP2283011B1 (de) 2011-11-23
JP5374578B2 (ja) 2013-12-25
CA2719569C (en) 2016-06-07
KR20100132541A (ko) 2010-12-17
CA2719569A1 (en) 2009-10-15
ZA201008052B (en) 2012-04-25
JP2011516539A (ja) 2011-05-26
KR101610417B1 (ko) 2016-04-07
CN101998953A (zh) 2011-03-30
NZ589169A (en) 2012-06-29
WO2009125365A1 (en) 2009-10-15
EP2283011A1 (de) 2011-02-16
ES2376820T3 (es) 2012-03-20
MX2010010932A (es) 2010-11-05

Similar Documents

Publication Publication Date Title
DK2308877T3 (da) Imidazopyridin-2-on-derivater
DK2164844T3 (da) Pyrimidinyl-pyridazinonderivater
DK2209786T3 (da) Pyrimidinsubstituerede purinderivater
BRPI0915064A2 (pt) derivados de qunoxalinadiona
DE602009000234D1 (de) msignals
BRPI0907376A2 (pt) Fotobiorretador
EP2376493A4 (de) Dihydropyrimidopyrimidinderivat
EP2380877A4 (de) Pyridin-3-carbonsäureamidderivat
BRPI0813836A2 (pt) Derivados pirazólicos
BRPI0913832A2 (pt) derivados de pirrolopiridinilpirimidin-2-ilamina
DE602008003521D1 (de) Sitzrücklehnungsmechanismus
ATE518837T1 (de) Indazolamidderivate
DK2275414T3 (da) Cyclopentylacrylamidderivat
DK2335031T3 (da) In-line-måler
EP2336132A4 (de) Morpholinpurinderivat
DK2152370T3 (da) Aryletherpyridazinonderivater
DK2271613T3 (da) Hydroxymethylcyklohexylaminer
ATE545635T1 (de) Substituierte n-oxidpyrazinderivate
BRPI0922652A2 (pt) Derivados de quinazolinamida
BRPI0913234A2 (pt) derivados de tiazolilpiperidina
BRPI0907522A2 (pt) biarlamidas
DE112009000183A5 (de) Sicherheitsvorreiber
ATE519760T1 (de) Isoxazolimidazolderivate
ATE534634T1 (de) 2-phenyl-4-cyclopropyl-pyrimidinderivate
BRPI0909634A2 (pt) 2-aminoquinolinas